Serveur d'exploration sur le lymphœdème - Exploration (Accueil)

Index « Mesh.i » - entrée « Drug Administration Schedule »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Administration Routes < Drug Administration Schedule < Drug Antagonism  Facettes :

List of bibliographic references indexed by Drug Administration Schedule

Number of relevant bibliographic references: 94.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000453 (2017) Silvia Cabral [Brésil] ; Cristine Bonfim [Brésil] ; Rosalira Oliveira [Brésil] ; Paula Oliveira [Brésil] ; Terezinha Guimarães [Brésil] ; Eduardo Brandão [Brésil] ; Ana Maria Aguiar-Santos [Brésil] ; Zulma Medeiros [Brésil]Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration.
000F79 (2016) Alison Krentel [Royaume-Uni] ; Rita Damayanti [Indonésie] ; Christiana Rialine Titaley [Indonésie] ; Nugroho Suharno [Indonésie] ; Mark Bradley [Royaume-Uni] ; Timothy Lynam [Australie]Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
001684 (2015) K. Papp [Canada] ; D. Thaçi [Allemagne] ; K. Reich [Allemagne] ; E. Riedl [Autriche] ; R G Langley [Canada] ; J G Krueger [États-Unis] ; A B Gottlieb [États-Unis] ; H. Nakagawa [Japon] ; E P Bowman [États-Unis] ; A. Mehta [États-Unis] ; Q. Li [États-Unis] ; Y. Zhou [États-Unis] ; R. Shames [États-Unis]Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial.
001803 (2015) Noriki Fujimoto [Japon] ; Mariko Mitsuru ; Toshihiro TanakaSuccessful treatment of Morbihan disease with long-term minocycline and its association with mast cell infiltration.
001889 (2015) M. Kalimuthu [Inde] ; I P Sunish ; J. Nagaraj ; A. Munirathinam ; V Ashok Kumar ; N. Arunachalam ; G B White ; B K TyagiResidual microfilaraemia in rural pockets of South India after five rounds of DEC plus albendazole administration as part of the LF elimination campaign.
001971 (2015) Tekola Endeshaw [Éthiopie] ; Aseged Taye [Éthiopie] ; Zerihun Tadesse [Éthiopie] ; Moses N. Katabarwa [États-Unis] ; Oumer Shafi [Éthiopie] ; Tewodros Seid [Éthiopie] ; Frank O. Richards [États-Unis]Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia
001C72 (2015) I. P. Sunish ; R. Rajendran ; A. Munirathinam ; M. Kalimuthu ; V. Ashok Kumar ; J. Nagaraj ; B. K. TyagiImpact on prevalence of intestinal helminth infection in school children administered with seven annual rounds of diethyl carbamazine (DEC) with albendazole
001F26 (2015) I P Sunish [Inde] ; M. Kalimuthu [Inde] ; R. Rajendran [Inde] ; A. Munirathinam [Inde] ; V. Ashok Kumar [Inde] ; J. Nagaraj [Inde] ; B K Tyagi [Inde]Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
002006 (2015) Israt Hafiz [Royaume-Uni] ; Patricia Graves [Australie] ; Rouseli Haq [Bangladesh] ; Meerjady Sabrina Flora [Bangladesh] ; Louise A. Kelly-Hope [Royaume-Uni]Clinical case estimates of lymphatic filariasis in an endemic district of Bangladesh after a decade of mass drug administration.
002716 (2014) I P Sunish [Inde] ; A. Munirathinam [Inde] ; M. Kalimuthu [Inde] ; V. Ashok Kumar [Inde] ; B K Tyagi [Inde]Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations.
002C05 (2014) Bontha V. Babu [Oman] ; Gopalan R. Babu [Inde]Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.
002D86 (2014) Karim Fizazi [France] ; Christophe Massard [France] ; Petri Bono [Finlande] ; Robert Jones [Royaume-Uni] ; Vesa Kataja [Finlande] ; Nicholas James [Royaume-Uni] ; Jorge A. Garcia [États-Unis] ; Andrew Protheroe [Royaume-Uni] ; Teuvo L. Tammela [Finlande] ; Tony Elliott [Royaume-Uni] ; Leena Mattila [Finlande] ; John Aspegren [Finlande] ; Annamari Vuorela [Finlande] ; Peter Langmuir [États-Unis] ; Mika Mustonen [Finlande]Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial.
003040 (2013) B. Nandha [Inde] ; K. Krishnamoorthy ; P. JambulingamTowards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
003119 (2013) K D Ramaiah [Inde] ; P. VanamailSurveillance of lymphatic filariasis after stopping ten years of mass drug administration in rural communities in south India.
003770 (2013) Patricia Moody Mcnab [États-Unis] ; Brian Christopher Quigley ; L Frank Glass ; Drazen M. JukicComposite hemangioendothelioma and its classification as a low-grade malignancy.
003947 (2013) Prajna Gayen [Inde] ; Ananya Nayak ; Prasanta Saini ; Niladri Mukherjee ; Sudipta Maitra ; Prasanta Sarkar ; Santi P. Sinha BabuA double-blind controlled field trial of doxycycline and albendazole in combination for the treatment of bancroftian filariasis in India.
004D39 (2011) Soumya Abrous-Anane [France] ; Alexia Savignoni ; Caroline Daveau ; Jean-Yves Pierga ; Chantal Gautier ; Fabien Reyal ; Remi Dendale ; François Campana ; Youlia M. Kirova ; Alain Fourquet ; Marc A. BolletManagement of inflammatory breast cancer after neoadjuvant chemotherapy.
004E13 (2011) Dhamodharan Ramasamy [Inde] ; Hoti Sugeerappa Laxmanappa ; Rohit Sharma ; Manoj Kumar DasInfluence of anti-filarial chemotherapy strategies on the genetic structure of Wuchereria bancrofti populations.
004E22 (2011) Jonathan D. King [États-Unis] ; Emily Zielinski-Gutierrez ; Molisamoa Pa'Au ; Patrick LammieImproving community participation to eliminate lymphatic filariasis in American Samoa.
004F27 (2011) K D Ramaiah [Inde] ; P. Vanamail ; J. Yuvaraj ; P K DasEffect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India.
005924 (2010) Moses J. Bockarie [Royaume-Uni] ; Rinki M. DebElimination of lymphatic filariasis: do we have the drugs to complete the job?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Drug Administration Schedule" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Drug Administration Schedule" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Drug Administration Schedule
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024